Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 10716766 Topical regional neuro-affective therapy with cannabinoids
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 23 Oct, 2024
"update inverses"
Golden AI
edited on 23 Oct, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12121617 Transdermal delivery of cannabidiol
0
Edits on 26 Jun, 2024
"update inverses"
Golden AI
edited on 26 Jun, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12016829 Pharmaceutical composition and method for treating seizure disorders
0
Edits on 19 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI
edited on 19 May, 2023
Edits made to:
Infobox
(
-1
properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10716766
Edits on 8 Jun, 2022
"Entity importer update"
Golden AI
edited on 8 Jun, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10716766
Edits on 5 Feb, 2022
"Created via: Entity Importer"
Golden AI
created this topic on 5 Feb, 2022
Edits made to:
Infobox
(
+7
properties)
US Patent 10716766 Topical regional neuro-affective therapy with cannabinoids
Infobox
Is a
Patent
Patent jurisdiction
United States Patent and Trademark Office
Patent number
10716766
Date of patent
July 21, 2020
Patent application number
15058946
Date Filed
March 2, 2016
Patent primary examiner
Snigdha Maewall
Find more entities like US Patent 10716766 Topical regional neuro-affective therapy with cannabinoids
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE